Dan W. Gladney

Dan W. Gladney (chief executive) discloses dealings in 2 companies, chiefly ReShape Lifesciences Inc. and Compex Technologies Inc. Between 24 February 2006 and 10 September 2021, the trades on record add up to 5 filings.

The open-market side counts 2 purchases for €180k alongside 1 sale for €506k. Netting one side against the other leaves €326k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. So far in 2021, the count stands at no purchases and 1 sale.

Most recently, on 17 September 2021, the filings show an open-market sale worth €506k in ReShape Lifesciences Inc. The clock since the last published purchase (18 May 2016) now reads 3,811 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 7 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.